Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Amgen inc.    crawled date : 2021 - 12 - 01    save search

Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors
Published: 2021-12-01 (Crawled : 22:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.62% H: 0.0% C: 0.0%
SPPI | $1.03 -0.97% 0 twitter stocktwits trandingview |
Health Technology
| | O: 1.59% H: 13.12% C: 5.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 2.59% C: 0.18%


Amgen Announces Positive Top-Line Results From Otezla® (apremilast) Phase 3 DISCREET Study In Moderate To Severe Genital Psoriasis
Published: 2021-12-01 (Crawled : 22:00) - biospace.com/
BGNE | $144.0 3.61% 3.48% 220K twitter stocktwits trandingview |
Health Technology
| | O: 3.7% H: 3.74% C: -0.91%
AMGN | News | $273.085 -0.17% -0.17% 2.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 2.59% C: 0.18%

psoriasis positive results phase 3 topline
U.S. FDA Approves DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Carfilzomib and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse
Published: 2021-12-01 (Crawled : 21:00) - biospace.com/
GNMSF | News | $290.34 3.83% 340 twitter stocktwits trandingview |
Health Technology
| | O: -0.54% H: 3.8% C: 2.35%
JNJ | News | $148.53 -0.69% -0.14% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.03% H: 2.04% C: 0.76%
GMAB | News | $28.47 -0.32% -0.32% 460K twitter stocktwits trandingview |
Health Technology
| | O: 0.55% H: 0.59% C: -1.88%
AMGN | News | $273.085 -0.17% -0.17% 2.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 2.59% C: 0.18%

fda
FDA Approves New KYPROLIS® (carfilzomib) Combination Regimen With DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) and dexamethasone For Patients With Multiple Myeloma At First Or Subsequent Relapse
Published: 2021-12-01 (Crawled : 19:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.26% H: 0.0% C: 0.0%
BGNE | $144.0 3.61% 3.48% 220K twitter stocktwits trandingview |
Health Technology
| | O: 0.69% H: 0.0% C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.03% H: 1.18% C: 0.22%

fda
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.